BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:26 PM
 | 
Nov 05, 2009
 |  BC Extra  |  Company News

Micromet regains full blinatumomab rights

Micromet Inc. (NASDAQ:MITI) ended a 2003 deal with MedImmune LLC and bought out all remaining rights to blinatumomab ( MT103) and other bispecific...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >